Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct;194(10):4702-4723.
doi: 10.1007/s12010-022-04072-7. Epub 2022 Jul 13.

Potential Bioactive Compounds from Marine Streptomyces sp. and Their In Vitro Antibiofilm and Antibacterial Activities Against Antimicrobial-Resistant Clinical Pathogens

Affiliations

Potential Bioactive Compounds from Marine Streptomyces sp. and Their In Vitro Antibiofilm and Antibacterial Activities Against Antimicrobial-Resistant Clinical Pathogens

Ranjithkumar Dhandapani et al. Appl Biochem Biotechnol. 2022 Oct.

Abstract

Antimicrobial resistance issues have risen dramatically in recent years, posing a severe concern to humans worldwide. The urgent need to find novel compounds for pharmaceutical applications prompts the research of under-explored environments such as marine ecosystems. The present study was designed to discover novel secondary metabolites, and we have isolated about 30 actinomycetes from the marine soil samples collected in Thondi (Ramanathapuram, Tamil Nadu, India), where most isolates are associated with the genus Streptomyces. Out of 30, one potentially active strain (Streptomyces sp. SRMA3) was identified using primary and secondary screening methods against the drug-resistant clinical pathogens. The active metabolites extracted from the selected active isolate were subjected to partial purification and characterization using Fourier transform infrared spectrophotometer (FTIR) and gas chromatography-mass spectroscopy (GC-MS) analysis. The minimum inhibitory concentration (MIC) value was determined for the active metabolite. Further, the partially purified active fraction was revealed for its antibacterial and antibiofilm activity against drug-resistant clinical pathogens. Light and fluorescence microscopy detected the viability and adhesion of the biofilm-forming drug-resistant pathogens. Growth curve analysis showed that the active metabolite has the potential to inhibit drug-resistant pathogens. The synergistic effect of active metabolite with commercial antibiotics also revealed that it could enhance the activity of antibiotics in antimicrobial resistance pathogens. This study shows that the isolated Streptomyces sp. SRMA3 is a potentially active strain, and the metabolite derived from this strain has a good antibacterial and antibiofilm activity against antimicrobially resistant clinical pathogens and could be used for various biotechnological applications.

Keywords: Antibacterial; Antibiofilm; Antimicrobial resistance; GC-MS; Streptomyces.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Goodfellow, M., & Williams, S. (1983). Ecology of actinomycetes. Annual Review of Microbiology, 37, 189–216. - PubMed - DOI
    1. Catalano, A., Iacopetta, D., Ceramella, J., Scumaci, D., Giuzio, F., Saturnino, C., Aquaro, S., Rosano, C., & Sinicropi, M. S. (2022). Multidrug resistance (MDR): A widespread phenomenon in pharmacological therapies. Molecules, 27, 616. - PubMed - PMC - DOI
    1. Alqahtani, S. S., Moni, S. S., Sultan, M. H., Bakkari, M. A., Madkhali, O. A., Alshahrani, S., Makeen, H. A., Menachery, S. J., ur Rehman, Z., Alam, M. S. (2022) Potential bioactive secondary metabolites of Actinomycetes sp. isolated from rocky soils of the heritage village Rijal Alma, Saudi Arabia. Arabian Journal of Chemistry, 15, 103793.
    1. Zhu, Y., Huang, W. E., & Yang, Q. (2022). Clinical perspective of antimicrobial resistance in bacteria. Infection and Drug Resistance, 15, 735–746. - PubMed - PMC - DOI
    1. Rafailidis, P. I., & Kofteridis, D. (2022). Proposed amendments regarding the definitions of multidrug-resistant and extensively drug-resistant bacteria. Expert Review of Anti-Infective Therapy, 20, 139–146. - PubMed - DOI

LinkOut - more resources